|LETTER TO THE EDITOR
|Year : 2018 | Volume
| Issue : 5 | Page : 258
Re: Outcome of second-look transurethral resection of bladder tumors for T1 bladder cancer: A five-year
Wen-Hsin Tseng1, Alex Chien-Hwa Liao1, Steven K Huang1, Chien-Liang Liu2
1 Department of Surgery, Division of Urology, Chi Mei Medical Center, Tainan, Taiwan
2 Department of Surgery, Division of Urology, Chi Mei Medical Center; Department of Surgery, Division of Uro-Oncology, Chi Mei Medical Center, Tainan, Taiwan
|Date of Web Publication||3-Sep-2018|
Alex Chien-Hwa Liao
Department of Surgery, Division of Urology, Chi Mei Medical Center, Tainan
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Tseng WH, Liao AC, Huang SK, Liu CL. Re: Outcome of second-look transurethral resection of bladder tumors for T1 bladder cancer: A five-year. Urol Sci 2018;29:258
|How to cite this URL:|
Tseng WH, Liao AC, Huang SK, Liu CL. Re: Outcome of second-look transurethral resection of bladder tumors for T1 bladder cancer: A five-year. Urol Sci [serial online] 2018 [cited 2019 Sep 17];29:258. Available from: http://www.e-urol-sci.com/text.asp?2018/29/5/258/240364
We wish to express our utmost gratitude to the readers. We know that bladder cancer is multifocal, with a high recurrence rate. Therefore, the NCCN guidelines and EAU guidelines all strongly advise repeat transurethral resection of bladder tumor (TURBT) for T1 bladder urothelial carcinoma., There are many reports showing that pathological stage of the tumor was underestimated in 9%–49% of patients with nonmuscle-invasive bladder cancer after thefirst TURBT, especially in patients with T1 bladder cancer. The rate of occurrence of residual tumor of T1 bladder cancer from second-look TURBT was 18% in our Chi Mei Medical Center, and this residual tumor rate is relatively low, in comparison with other published studies between 32.9% and 77.6%.,,,,,, Second-look TURBT is a useful tool for early diagnosis of residual tumors and restaging, which could help us in deciding the subsequent treatment step if tumor was found. Thanks for the comments.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al.
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. Eur Urol 2017;71:447-61.
Miladi M, Peyromaure M, Zerbib M, Saïghi D, Debré B. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol 2003;43:241-5.
Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999;162:74-6.
Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early? J Urol 2001;165:808-10.
Schips L, Augustin H, Zigeuner RE, Gallé G, Habermann H, Trummer H, et al.
Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002;59:220-3.
Zurkirchen MA, Sulser T, Gaspert A, Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: A must even for experienced urologists. Urol Int 2004;72:99-102.
Divrik T, Yildirim U, Eroğlu AS, Zorlu F, Ozen H. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 2006;175:1258-61.
Schwaibold HE, Sivalingam S, May F, Hartung R. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006;97:1199-201.
Han KS, Joung JY, Cho KS, Seo HK, Chung J, Park WS, et al.
Results of repeated transurethral resection for a second opinion in patients referred for nonmuscle invasive bladder cancer: The referral cancer center experience and review of the literature. J Endourol 2008;22:2699-704.